Skip to 0 minutes and 14 seconds In one of our most challenging programmes, we engage with Professor Mark Cook, a neurologist at St. Vincent’s Hospital in Melbourne. OK, so epilepsy is really common. I guess most people don’t realise it’s the second most common serious neurological disease. Stroke’s the most important. But epilepsy is really common, and no one knows it because of the stigma around and the fact that people don’t discuss it openly. But 1% of the world’s population have epilepsy chronically, so they’re having recurrent seizures, and 5%, maybe as many as 8% have seizures during their life. So it’s a really common problem.
Skip to 0 minutes and 46 seconds Of that 1% of the whole world’s population, though, that have epilepsy, about 60% are controlled with medications that we have available currently, but the rest aren’t properly controlled, and so they’re still having active seizures. Even the people who are controlled are often putting up with a lot of bad side effects from the medications that are controlling their seizures. So there’s plenty of opportunities to improve the situation, and we’re not talking about some rare and uncommon problem, we’re talking about what’s a really serious disease burden for the whole of mankind. Our goal is to develop an implantable system for epilepsy detection and control. Electrical signals arising from the brain can be used to warn of an impending seizure.
Skip to 1 minute and 28 seconds We will couple this warning system to a nanostructured reservoir containing anti-epileptic drugs. All components integrated into a fully implantable device. Upon detection of an emerging seizure, drug is released when and where it is needed and can act quickly to prevent a seizure occurring. Success in this area is dependent on the effective integration of advances in a number of somewhat disparate technological areas. It will be challenging, but success is possible. We’re realising that a lot of problems associated with the brain malfunctions are concerned with this network properties, and at the moment we don’t have good methods of studying how these networks function in using a real system.
Skip to 2 minutes and 14 seconds Making these three-dimensional systems with stem cells or other living cells gives us a good way of looking how simple but realistic networks of neurons function, how to disturb it, how to fix it. At the moment we work with these 2D arrays, where we can study the connections between cells and their response to various stimuli, including drugs and chemicals that produce seizures, for instance. And we’ve got a lot of experience studying that in 2D. But the behaviour of these systems alters considerably when you move into the 3D world, and of course that’s the real world.
Skip to 2 minutes and 45 seconds So being able to create synthetic structures out of real cells that are connected in three dimensions might give us new ways to, for instance, test drugs, or to test other therapies. So it’s really exciting. So how many layers of different types of cells do you think we would need to print to start to get meaningful information? Well, I think we’ll get meaningful information just through having neurons connected. So just one type of cell, provided they’re connected well and they’re interacting, and we’ve seen that that happens in these 3D structures.
Skip to 3 minutes and 14 seconds We could certainly make it more complex, introducing other cells that are present in the brain, the supporting cells, the glia of the brain, which have also turned out to be quite important in the way the brain works, rather than just providing mechanical support. Being able to include them in the system as well, that would also make for much more sophisticated environments where we might get a much better idea not only of how the brain works in these artificial structures but how it works in real life. The cortex, for instance, is about two to three millimetres thick in humans. Getting those sorts of thicknesses, I think, is achievable with these artificial structures at the moment.
Skip to 3 minutes and 51 seconds So I see that building artificial structures that are broadly similar to the pattern of normal cortex as possible, of course, is very sophisticated, and the interconnections are far more elaborate than we could possibly hope to imitate now, but we’ve seen in other situations that simple models of living systems can give us great insights into how the normal systems function and more importantly how abnormal systems function. So we could do that with these systems, potentially. And again, might lead to revolutionary different therapies and different ways of intervening in the disease development?
Skip to 4 minutes and 25 seconds Absolutely, and I guess the real blue sky thing is, could we create a 3D object that we could use to transplant directly into a brain to replace damaged or missing parts? That would be really exciting. I mean, that’s obviously some way off yet.
Remedies of the future
The prevalence of epilepsy goes largely unnoticed.
More than 60 million people have epilepsy. Up to two thirds of this population are treated adequately with medication. That leaves a lot of people who cannot access treatment for one reason or another or people who are not suitable for treatment.
“Many of the standard treatments involving ingesting medications that soak your whole body and brain, and your body doesn’t like them. They cause bad side effects, most particularly side effects on the central nervous system. They slow your mind, they effect your ability to perform and as well they have lots of other effects, tension on the liver, bones and other tissue they are not good drugs. Could we get them to our target in a different way? Are there better ways we could treat epilepsy?” (Cook, 2012)
Learn more about these emerging treatments for epilepsy
TEDxUWollongong talk (2012) on the development of groundbreaking medical implants for the treatment of epilepsy
Fit bit for the Brain (2017) ABC news article showing the progress of the treatment.
- What other ways could 3D bioprinting be used to research new treatments?
© University of Wollongong, 2020